Report
Chris Kallos, CFA
EUR 101.80 For Business Accounts Only

Ebos Group is a trans-Tasman conglomerate highly leveraged to the Australian healthcare market.

We maintain our fair value estimate of NZD 17.00 per share (AUD 16.00 per share using an Australian dollar/NZ dollar exchange rate of 1.07) for narrow-moat Ebos Group after a strong interim result, albeit one within our range of expectations. Specifically, Ebos posted underlying net profit after tax of NZD 70.2 million on group revenue of NZD 3,960 million, up 13% and 21%, respectively, year on year, buoyed by the positive impact of new hepatitis C drugs launched in 2016, the merger with the Ter...
Underlying
Ebos Group

EBOS Group is a provider of medical and healthcare products to the human and animal markets. Co. operates in two business segments, being Healthcare, which incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities, and logistics; as well as Animal Care, which incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Co.'s operations are primarily in New Zealand and Australia.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Chris Kallos, CFA

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch